Mangrove Partners Mesoblast LTD Put Options Transaction History

Mangrove Partners

  • $890 Million
  • Q2 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$8.21 - $18.59 $5.54 Million - $12.6 Million
-675,300 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$11.33 - $19.81 $7.65 Million - $13.4 Million
675,300 New
675,300 $12.6 Million

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $944M
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email